Editas Medicine
Stock Forecast, Prediction & Price Target
Editas Medicine Financial Estimates
Editas Medicine Revenue Estimates
Editas Medicine EBITDA Estimates
Editas Medicine Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $25.54M N/A | $19.71M -22.83% | $78.12M 296.32% | Avg: $27.62M Low: $27.62M High: $27.62M avg. -64.63% | Avg: $65.25M Low: $65.25M High: $65.25M avg. 136.21% | Avg: $187.78M Low: $187.78M High: $187.78M avg. 187.75% | Avg: $301.13M Low: $301.13M High: $301.13M avg. 60.36% |
Net Income
% change YoY
| $-185.10M N/A | $-204.35M -10.39% | $-153.21M 25.02% | Avg: $-198.56M Low: $-198.56M High: $-198.56M avg. -29.59% | Avg: $-203.54M Low: $-203.54M High: $-203.54M avg. -2.50% | Avg: $-124.49M Low: $-124.49M High: $-124.49M avg. 38.83% | Avg: $-58.20M Low: $-58.20M High: $-58.20M avg. 53.24% |
EBITDA
% change YoY
| $-193.14M N/A | $-225.95M -16.98% | $-163.11M 27.80% | Avg: $-27.62M Low: $-27.62M High: $-27.62M avg. 83.06% | Avg: $-65.25M Low: $-65.25M High: $-65.25M avg. -136.21% | Avg: $-187.78M Low: $-187.78M High: $-187.78M avg. -187.75% | Avg: $-301.13M Low: $-301.13M High: $-301.13M avg. -60.36% |
EPS
% change YoY
| -$2.74 N/A | -$2.98 -8.75% | -$2.02 32.21% | Avg: -$2.61 Low: -$2.61 High: -$2.61 avg. -29.39% | Avg: -$2.68 Low: -$2.68 High: -$2.68 avg. -2.50% | Avg: -$1.64 Low: -$1.64 High: -$1.64 avg. 38.83% | Avg: -$0.77 Low: -$0.77 High: -$0.77 avg. 53.24% |
Operating Expenses
% change YoY
| $218.69M N/A | $245.66M 12.33% | $247.30M 0.66% | Avg: $62.71M Low: $62.71M High: $62.71M avg. -74.64% | Avg: $148.13M Low: $148.13M High: $148.13M avg. 136.21% | Avg: $426.26M Low: $426.26M High: $426.26M avg. 187.75% | Avg: $683.56M Low: $683.56M High: $683.56M avg. 60.36% |
FAQ
What is Editas Medicine stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 14.99% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is -198.56M, average is -198.56M and high is -198.56M.
What is Editas Medicine stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 79.92% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $27.62M, average is $27.62M and high is $27.62M.
What is Editas Medicine stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 15.04% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$2.61, average is -$2.61 and high is $-2.61.